My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
AgendaItemPacket_SHsignature
>
Meetings
>
2024
>
08. August
>
2024-08-06 10:00 AM - Commissioners' Agenda
>
AgendaItemPacket_SHsignature
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
8/1/2024 1:14:10 PM
Creation date
8/1/2024 1:07:57 PM
Metadata
Fields
Template:
Meeting
Date
8/6/2024
Meeting title
Commissioners' Agenda
Location
Commissioners' Auditorium
Address
205 West 5th Room 109 - Ellensburg
Meeting type
Regular
Meeting document type
Supporting documentation
Supplemental fields
Item
Request to Approve a Resolution Accepting the Kroger Co. Multi-State Settlement Agreement
Order
2
Placement
Consent Agenda
Row ID
120774
Type
Resolution
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
58
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
6. Nothing in this MOU should alter or change any Participating <br />Local Government's rights to pursue its own claim. Rather, the intent of <br />this MOU is to join all parties who wish to be Participating Local <br />Governments to agree upon an allocation formula for any Opioid Funds <br />from any future binding Settlement with one or more Pharmaceutical <br />Supply Chain Participants for all Local Governments in the State of <br />Washington. <br />7. If any Participating Local Government disputes the amount it <br />receives from its allocation of Opioid Funds, the Participating Local <br />Government shall alert its respective OAC within sixty (60) days of <br />discovering the information underlying the dispute. Failure to alert its <br />OAC within this time frame shall not constitute a waiver of the <br />Participating Local Government's right to seek recoupment of any <br />deficiency in its allocation of Opioid Funds. <br />8. If any OAC concludes that a Participating Local Government's <br />expenditure of its allocation of Opioid Funds did not comply with the <br />Approved Purposes listed in Exhibit A, or the terms of this MOU, or that <br />the Participating Local Government otherwise misused its allocation of <br />Opioid Funds, the OAC may take remedial action against the alleged <br />offending Participating Local Government. Such remedial action is left to <br />the discretion of the OAC and may include withholding future Opioid <br />Funds owed to the offending Participating Local Government or requiring <br />the offending Participating Local Government to reimburse improperly <br />expended Opioid Funds back to the OAC to be re -allocated to the <br />remaining Participating Local Governments within that Region. <br />9. All Participating Local Governments and OAC shall maintain all <br />records related to the receipt and expenditure of Opioid Funds for no less <br />than five (5) years and shall make such records available for review by <br />any other Participating Local Government or OAC, or the public. Records <br />requested by the public shall be produced in accordance with <br />Washington's Public Records Act RCW 42.56.001 et seq. Records <br />requested by another Participating Local Government or an OAC shall be <br />produced within twenty-one (21) days of the date the record request was <br />received. This requirement does not supplant any Participating Local <br />Government or OAC's obligations under Washington's Public Records <br />Act RCW 42.56.001 et seq. <br />D. Payment of Counsel and Litigation Expenses <br />1. The Litigating Local Governments have incurred attorneys' fees <br />and litigation expenses relating to their prosecution of claims against the <br />Pharmaceutical Supply Chain Participants, and this prosecution has inured to the <br />benefit of all Participating Local Governments. Accordingly, a Washington <br />8 <br />
The URL can be used to link to this page
Your browser does not support the video tag.